Regadenoson

This classification denotes a vasodilating agent with the molecular formula C15H18N8O5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XLN4Y044H, chemically known as adenosine, 2-(4-((methylamino)carbonyl)-1h-pyrazol-1-yl)- but generally known as regadenoson, which bears US NIH Compound Identifier 219024. European Medicines Agency schedules Regadenoson in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30494. World Health Organization schedules regadenoson in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule regadenoson under HS 29349990 and SITC 51579. As of Q4 2014, REGADENOSON remains the US FDA Preferred Term for this commodity. Regadenoson bears US NLM identifiers UMLS ID C1698215 and NCI Concept Code C74420. SMILES: O1C(n2c3nc(nc(N)c3nc2)n2ncc(c2)C(=O)NC)C(O)C(O)C1CO.